What is NDC 62175-313?

62175-313 is the product NDC for Methylphenidate Hydrochloride, Methylphenidate hydrochloride 54 mg/1 tablet, extended release, listed with the FDA by Lannett Company, Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.

Lannett Company, Inc., NDC labeler code 62175. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Methylphenidate Hydrochloride?

148 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Methylphenidate Hydrochloride NDC 62175-313

NDC codes

FDA NDC Directory

Product NDC (as listed)62175-313Labeler and product segments. Claims need a package NDC.

Product NDC at billing width62175-0313Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
62175-313-37	6217503133762175031337	100 TABLET, EXTENDED RELEASE in 1 BOTTLE (62175-313-37)Marketed from Sep 23, 2013

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Methylphenidate Hydrochloride
Generic name (nonproprietary): methylphenidate hydrochloride
Active ingredients: Methylphenidate hydrochloride — 54 mg/1
Dosage form: Tablet, Extended release
Route: Oral
Labeler: Lannett Company, Inc.NDC labeler code 62175
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 091695
Marketing start: Sep 23, 2013
Listing expires: Dec 31, 2027
DEA schedule: CII
Other FDA classes: Central Nervous System Stimulation (Physiologic effect)
Identifiers: Product ID 62175-313_8b133cd2-e3c6-4742-b402-2393b56ffc93SPL ID 8b133cd2-e3c6-4742-b402-2393b56ffc93SPL set ID 3d1f5aff-5d39-496c-b5ed-7f3c70ec641cRxCUI 2001564, 2001565, 2001566, 2001568UNII 4B3SC438HIUPC 0362175312372, 0362175311375
Pharmacologic class: Central Nervous System Stimulant

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N462175031337 followed by a unit qualifier and the quantity

Package 62175-0313-37. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective May 1, 2026. This label includes a boxed warning.

Indications (excerpt from the label)

Methylphenidate HCl Extended-Release Tablets are indicated for the treatment of attention deficit hyperactivity disorder (ADHD) in patients aged 6 to 65 years old. Limitations of Use The use of Methylphenidate HCl Extended-Release Tablets is not recommended in pediatric patients younger than 6 years of age because they had higher plasma exposure and a higher incidence of adverse reactions (e.g., weight loss) than patients 6 years and older at the same dosage [see Warnings and Precautions (5.7) and Use in Specific Populations (8.4) ]. Methylphenidate HCl Extended-Release Tablets are a CNS stimulant indicated for the treatment of attention deficit hyperactivity disorder (ADHD) in patients aged…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 62175-313

What is NDC 62175-313?: 62175-313 is the product NDC for Methylphenidate Hydrochloride, Methylphenidate hydrochloride 54 mg/1 tablet, extended release, listed with the FDA by Lannett Company, Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Methylphenidate Hydrochloride.
What is the active ingredient?: Methylphenidate hydrochloride.
Who is the labeler?: Lannett Company, Inc., NDC labeler code 62175. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Methylphenidate Hydrochloride?: 148 other product NDCs are listed under this name. See all Methylphenidate Hydrochloride NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Methylphenidate Hydrochloride NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Methylphenidate Hydrochloride	Methylphenidate hydrochloride 72 mg/1	Tablet, Extended releaseOral	Northstar Rx LLC	72603-399	72603-0399-01
Methylphenidate Hydrochloride	Methylphenidate hydrochloride 72 mg/1	Tablet, Extended releaseOral	Sun Pharmaceutical Industries, Inc.	57664-710	57664-0710-8357664-0710-88
Methylphenidate Hydrochloride	Methylphenidate hydrochloride 10 mg/1	TabletOral	Bryant Ranch Prepack	71335-2968	71335-2968-01
Methylphenidate Hydrochloride	Methylphenidate hydrochloride 5 mg/1	TabletOral	Bryant Ranch Prepack	72162-2428	72162-2428-01
Methylphenidate Hydrochloride	Methylphenidate hydrochloride 10 mg/1	TabletOral	Bryant Ranch Prepack	72162-2429	72162-2429-01
Methylphenidate Hydrochloride	Methylphenidate hydrochloride 20 mg/1	TabletOral	Bryant Ranch Prepack	72162-2430	72162-2430-01
Methylphenidate Hydrochloride	Methylphenidate hydrochloride 5 mg/1	TabletOral	Nivagen Pharmaceuticals, Inc.	75834-324	75834-0324-01
Methylphenidate Hydrochloride	Methylphenidate hydrochloride 10 mg/1	TabletOral	Nivagen Pharmaceuticals, Inc.	75834-325	75834-0325-01
Methylphenidate Hydrochloride	Methylphenidate hydrochloride 20 mg/1	TabletOral	Nivagen Pharmaceuticals, Inc.	75834-326	75834-0326-01
Methylphenidate Hydrochloride	Methylphenidate hydrochloride 63 mg/1	Tablet, Extended releaseOral	Trigen Laboratories, LLC	13811-700	13811-0700-30

All 149 Methylphenidate Hydrochloride NDCs

Other NDCs under ANDA 091695

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 091695
Product	Strength	Form · route	Labeler	Product NDC
Methylphenidate Hydrochloride	Methylphenidate hydrochloride 18 mg/1	Tablet, Extended releaseOral	Lannett Company, Inc.	62175-310
Methylphenidate Hydrochloride	Methylphenidate hydrochloride 27 mg/1	Tablet, Extended releaseOral	Lannett Company, Inc.	62175-311
Methylphenidate Hydrochloride	Methylphenidate hydrochloride 36 mg/1	Tablet, Extended releaseOral	Lannett Company, Inc.	62175-312
Methylphenidate Hydrochloride	Methylphenidate hydrochloride 36 mg/1	Tablet, Extended releaseOral	Bryant Ranch Prepack	72162-2394
Methylphenidate Hydrochloride	Methylphenidate hydrochloride 27 mg/1	Tablet, Extended releaseOral	Bryant Ranch Prepack	72162-2395